HOME >> MEDICINE >> NEWS
Study evaluates benefits and risks of tamoxifen and raloxifene for reducing risk of breast cancer

Raloxifene and tamoxifen are both effective in reducing the risk of invasive breast cancer, but each has potential disease and quality of life side effects that women and their physicians will need to consider, according to two reports and an editorial published online June 5 by JAMA. The papers are being published online to coincide with the scientific presentation of this information at the annual American Society of Clinical Oncology meeting in Atlanta. The papers will be published in the June 21 issue of JAMA.

Tamoxifen is a selective estrogen receptor modulator (SERM) that has been used to treat both early and advanced breast cancer for more than three decades, according to background information in the article. Raloxifene is a second-generation SERM currently used as a medication for the prevention and treatment of osteoporosis. But clinical trials have shown it may have a role in reducing the risk of invasive breast cancer in postmenopausal women.

Victor G. Vogel, M.D., M.H.S., from Magee-Womens Hospital, University of Pittsburgh School of Medicine, and colleagues from The National Surgical Adjuvant Breast and Bowel Project (NSABP), conducted a randomized clinical trial (Study of Tamoxifen and Raloxifene or STAR trial) at nearly 200 clinical centers throughout North America. Patients were 19,747 postmenopausal women with an average age of 58.5 years with an increased five-year breast cancer risk. The study patients were randomized to receive oral tamoxifen (20 mg/day) or raloxifene (60 mg/day) over five years.

"There were 163 cases of invasive breast cancer in women assigned to tamoxifen and 168 in those assigned to raloxifene (incidence, 4.30 per 1,000 vs. 4.41 per 1,000)," according to the study authors. There were fewer cases of noninvasive breast cancer in the tamoxifen group (57 cases) than in the raloxifene group (80 cases), while there were 36 cases of uterine cancer with tamoxifen and 23 with raloxifene; however, neit
'"/>

Contact: Clare Collins
412-352-2886
JAMA and Archives Journals
5-Jun-2006


Page: 1 2

Related medicine news :

1. Study, meta-analysis examine factors associated with death from heatstroke
2. Study says COPD testing is not measuring up
3. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
4. Study reveals gaps in vaccine financing for underinsured children
5. Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks
6. Study shows radiofrequency ablation highly effective in treating kidney tumors
7. Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer
8. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
9. Study outlines how stroke, head injury can increase risk of Alzheimers disease
10. Study identifies new regulator of fat metabolism
11. Study shows Diachrome improves blood sugar control in people with type 2 diabetes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2018)... ... August 17, 2018 , ... An August 7 article ... premature births and low birth weight could be significantly reduced if women were more ... gingivitis (gum disease) which a very large number of pregnant women suffer from to ...
(Date:8/15/2018)... ... August 15, 2018 , ... Today David Hyde Apparel debuts the first, fully ... out of a desire for confidence and comfort year-round, the new shirt leverages a ... in the hottest, most humid of climates. , The brainchild of two recent University ...
(Date:8/14/2018)... MIAMI (PRWEB) , ... August 14, 2018 , ... ... fastest-growing gastroenterology groups, today announced new leadership roles for healthcare executives Simon Frisch ... Division Vice President, Florida, respectively. They assume their roles at a time of ...
(Date:8/11/2018)... ... 10, 2018 , ... Dr. Siavash Eftekhari, Oral and Maxillofacial Surgeon at ... international outpost trip to deliver dental care in impoverished communities. Along with a team ... volunteered his time to help deliver care to over 550 individuals in need. , ...
(Date:8/9/2018)... ... August 09, 2018 , ... Thousands of US ... according to cross-referenced data from The American Society of Plastic Surgeons (ASPS), The ... monitored by the FDA. As an MRI is recommended by FDA after the ...
Breaking Medicine News(10 mins):
(Date:8/7/2018)... ... August 07, 2018 , ... ... of Richard A. Stark to assume the role of Sanarus Technologies President, effective immediately. Mr. ... of strategic development, marketing and sales experience in medical device toward finding new and ...
(Date:8/3/2018)... ... August 03, 2018 , ... In order to improve safety for everyone ... be mindful of the significant risks of injury that many amusement park rides present ... the Ferris wheel or a thrilling ride on a roller coaster. Unfortunately, these fun ...
(Date:8/2/2018)... ... August 02, 2018 , ... Periodontist, Dr. Andres ... crown lengthening treatment at his Eden Prairie, MN practice. Aesthetic crown ... self-conscious. Using decades of experience, Dr. Sanchez is excited to welcome new patients ...
Breaking Medicine Technology:
Cached News: